Drug news
MRI-Guided Radiation Therapy System (ViewRay) for Cancer treatment receives FDA 510(k) approval
The MRI-Guided Radiation Therapy System, from ViewRay, has received US FDA 510(k) premarket notification clearance. The system features a combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer and is designed to capture soft-tissue images continuously during treatment, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy. ViewRay's treatment planning and delivery software received 510(k) premarket notification clearance in 2011.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins